How Good Is Xoma’s Good News?

XOMA Establishes Proof-of-Concept for 358 in Congenital Hyperinsulinism and Hypoglycemia Post-Bariatric Surgery
Congenital Hyperinsulinism Phase 2 study completed and multi-dose study protocol approved in the United Kingdom.
Xoma initiates multi-dose study in hypoglycemic Post-Bariatric Surgery patients
A few days ago, Xoma announced news about trial results that the firm believes were promising and successful in establishing proof-of-concept for its . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.